Published in Br J Anaesth on July 09, 2011
Target-controlled infusion and population pharmacokinetics of landiolol hydrochloride in gynecologic patients. J Anesth (2014) 0.80
Target-controlled infusion and population pharmacokinetics of landiolol hydrochloride in patients with peripheral arterial disease. Ther Clin Risk Manag (2015) 0.75
The administration of high-dose propofol sedation with manual and target-controlled infusion in children undergoing radiation therapy: a 7-year clinical investigation. Springerplus (2016) 0.75
Population pharmacokinetics of intravenous acetaminophen in Japanese patients undergoing elective surgery. J Anesth (2017) 0.75
The predictive ability of six pharmacokinetic models of rocuronium developed using a single bolus: evaluation with bolus and continuous infusion regimen. J Anesth (2016) 0.75
Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet (2000) 8.10
Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature (1994) 4.42
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women. J Clin Oncol (1998) 3.65
A review of postoperative cognitive dysfunction and neuroinflammation associated with cardiac surgery and anaesthesia. Anaesthesia (2012) 3.47
Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol (1990) 3.31
Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet (1996) 3.17
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J Clin Invest (1998) 2.97
HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc Natl Acad Sci U S A (1991) 2.83
Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology (1997) 2.61
Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med (1994) 2.18
Florida's "truth" campaign: a counter-marketing, anti-tobacco media campaign. J Public Health Manag Pract (2000) 2.09
Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. J Clin Invest (1991) 2.08
Psychological effects of ketamine in healthy volunteers. Phenomenological study. Br J Psychiatry (2006) 2.06
T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology (1994) 2.00
Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology (2001) 1.99
Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B. J Immunol (1987) 1.85
Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein. J Virol (1993) 1.74
Nitrous oxide (N(2)O) reduces postoperative opioid-induced hyperalgesia after remifentanil-propofol anaesthesia in humans. Br J Anaesth (2011) 1.67
Short stay facilities: the future of efficient paediatric emergency services. Arch Dis Child (1996) 1.64
Anaesthetic neurotoxicity and neuroplasticity: an expert group report and statement based on the BJA Salzburg Seminar. Br J Anaesth (2013) 1.26
Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T cell lines. J Immunol (1987) 1.25
Selective sensitization of peripheral blood T lymphocytes to hepatitis B core antigen in patients with chronic active hepatitis type B. Clin Exp Immunol (1986) 1.14
Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial. J Viral Hepat (2008) 1.07
Cellular immune response to hepatitis B virus antigens. An overview. J Hepatol (1988) 1.05
Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: interaction with HLA and T-cell receptor. Hepatology (1997) 1.04
The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man. J Clin Invest (1989) 1.02
Pre-oxygenation in the obese patient: effects of position on tolerance to apnoea. Br J Anaesth (2005) 1.00
Sympathetic regulation of cerebral blood flow in humans: a review. Br J Anaesth (2013) 1.00
Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens. Hepatology (2001) 0.99
Systematic review: antibodies and anti-TNF-α levels in inflammatory bowel disease. Aliment Pharmacol Ther (2012) 0.99
Effect site concentrations of propofol producing hypnosis in children and adults: comparison using the bispectral index. Acta Anaesthesiol Scand (2006) 0.98
Parasitic diatoms inside antarctic sponges. Biol Bull (2000) 0.97
Immunopathogenesis of hepatitis C virus infection. J Hepatol (1999) 0.97
Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model. Br J Anaesth (2010) 0.96
Fine specificity of the human T-cell response to the hepatitis B virus preS1 antigen. Gastroenterology (1992) 0.95
Gonadotropin-releasing hormone action in the pituitary: a three step mechanism. Endocr Rev (1981) 0.93
Antiviral cell-mediated immune responses during hepatitis B and hepatitis C virus infections. Recent Results Cancer Res (1998) 0.92
Differences in the frequency and distribution of BRCA1 and BRCA2 mutations in breast/ovarian cancer cases from the Basque country with respect to the Spanish population: implications for genetic counselling. Breast Cancer Res Treat (2007) 0.91
Patient-maintained propofol sedation: a follow up safety study using a modified system in volunteers. Anaesthesia (2002) 0.90
Evaluation of the effect of intravenous lidocaine on propofol requirements during total intravenous anaesthesia as measured by bispectral index. Br J Anaesth (2012) 0.90
Immunosuppression with generic tacrolimus and mycophenolate mofetil in renal transplant recipients: preliminary report in Chile. Transplant Proc (2008) 0.89
Monitoring the efficacy of specific treatment in chronic Chagas disease by polymerase chain reaction and flow cytometry analysis. Parasite (2005) 0.86
Autopresentation of hepatitis B virus envelope antigens by T cells. J Virol (1992) 0.86
Purification of adhesive proteins from mussels. Protein Expr Purif (1990) 0.85
Detection and quantification of Prymnesium parvum (Haptophyceae) by real-time PCR. Lett Appl Microbiol (2007) 0.84
Inappropriate Halsted mastectomy and patient volume in Italian hospitals. Am J Public Health (1993) 0.83
LOH analysis should not be used as a tool to assess whether UVs of BRCA1/2 are pathogenic or not. Fam Cancer (2010) 0.83
Prospective evaluation of the time to peak effect of propofol to target the effect site in children. Acta Anaesthesiol Scand (2009) 0.83
Effectiveness of different therapeutic strategies in preventing diverticulitis recurrence. Eur Rev Med Pharmacol Sci (2013) 0.83
A pilot study of cerebral tissue oxygenation and postoperative cognitive dysfunction among patients undergoing coronary artery bypass grafting randomised to surgery with or without cardiopulmonary bypass*. Anaesthesia (2014) 0.82
Physicians' view of practice guidelines. A survey of Italian physicians. Soc Sci Med (1996) 0.81
The influence of patient characteristics on the appropriateness of surgical treatment for breast cancer patients. Progetto Oncologia Femminile. Ann Oncol (1993) 0.81
Green light for liver function monitoring using indocyanine green? An overview of current clinical applications. Anaesthesia (2014) 0.81
Electrochemical oxidation of phenolic wastes with boron-doped diamond anodes. Water Res (2005) 0.81
Optimizing intravenous drug administration by applying pharmacokinetic/pharmacodynamic concepts. Br J Anaesth (2011) 0.81
New insights into the biological and clinical significance of fecal calprotectin in inflammatory bowel disease. Immunopharmacol Immunotoxicol (2006) 0.80
Thymidine phosphorylase profiles in nonmalignant and malignant pancreatic tissue. Potential therapeutic role of capecitabine on tumoral and endothelial cells and tumor-infiltrating macrophages. Immunopharmacol Immunotoxicol (2005) 0.80
Cell mediated immune response to hepatitis B virus nucleocapsid antigen. Arch Virol Suppl (1993) 0.80
Effect-site targeted patient-controlled sedation with propofol: comparison with anaesthetist administration for colonoscopy. Anaesthesia (2006) 0.80
Expression and immunological evaluation of the Escherichia coli-derived hepatitis C virus envelope E1 protein. Biotechnol Appl Biochem (2000) 0.79
Bispectral index values and propofol concentrations at loss and return of consciousness in patients with frontal brain tumours and control patients. Br J Anaesth (2013) 0.79
Primary pure choriocarcinoma of the liver. Pathol Res Pract (1992) 0.79
Variation in use of breast surgery and characteristics of hospitals' surgical staff. Int J Qual Health Care (1994) 0.78
Effect of timing of morphine administration during remifentanil-based anaesthesia on early recovery from anaesthesia and postoperative pain. Br J Anaesth (2002) 0.78
Capture probe conjugated to paramagnetic nanoparticles for purification of Alexandrium species (Dinophyceae) DNA from environmental samples. J Appl Microbiol (2006) 0.78
[The nutritional status of patients with colorectal cancer undergoing chemotherapy]. Farm Hosp (2008) 0.78
Functional modulation of hepatitis B core antigen-specific T lymphocytes by an autoreactive T cell clone. J Immunol (1988) 0.78
Structural normalization of the lymphoid tissue in asymptomatic HIV-infected patients after 48 weeks of potent antiretroviral therapy. AIDS (2001) 0.78
Comparative study of red blood cell method in rat and calves blood as alternatives of Draize eye irritation test. Toxicol In Vitro (2005) 0.78
Immunological evaluation of Escherichia coli-derived hepatitis C virus second envelope protein (E2) variants. J Pept Res (2001) 0.78
Safety and effectiveness of infliximab for inflammatory bowel diseases in clinical practice. Eur Rev Med Pharmacol Sci (2010) 0.78
Letter: are infliximab and adalimumab similar for Crohn's disease in clinical practice? Aliment Pharmacol Ther (2013) 0.77
In vitro quantitative determination of ophthalmic irritancy by the chorioallantoic membrane test with trypan blue staining as alternative to eye irritation test. Toxicol In Vitro (2005) 0.77
[Anesthesia for electroconvulsive therapy: clinical experience]. Rev Esp Anestesiol Reanim (2007) 0.77
Neutralizing antibodies against the peptide antibiotic AS-48: immunocytological studies. Antimicrob Agents Chemother (1993) 0.76
Study on the oligosaccharides composition of the water-soluble fraction of marine mucilage by electrospray tandem mass spectrometry. Water Res (2007) 0.76
NIRS during therapeutic hypothermia: cool or hot? Resuscitation (2013) 0.76
PreS antigen expression and anti-preS response in hepatitis B virus infections: relationship to serum HBV-DNA, intrahepatic HBcAg, liver damage and specific T-cell response. Arch Virol Suppl (1992) 0.76
PTPL1 and PKCδ contribute to proapoptotic signalling in prostate cancer cells. Cell Death Dis (2013) 0.76
Airway obstruction caused by rheumatoid cricoarytenoid arthritis. Lancet (1998) 0.76
Letter: anti-TNFs and psoriasis--friends or foes? Aliment Pharmacol Ther (2012) 0.75
Awake insertion of the laryngeal mask airway using topical lidocaine and intravenous remifentanil. Anaesthesia (2006) 0.75
Adrenocortical function and steroid therapy in critical illness. Br J Anaesth (1999) 0.75
Mercaptopurine rescue after azathioprine-induced liver injury in inflammatory bowel disease. Aliment Pharmacol Ther (2010) 0.75
[Tetrabiguanide: hematic and urinary concentrations in humans]. Boll Soc Ital Biol Sper (1967) 0.75
[Effects of Tettuccio water from the Montecatini spa on chronic constipation: clinical evaluation and study of intestinal motor activity]. Clin Ter (1984) 0.75
[Climacteric symptomatology: relation with hormone levels and trophic features of the external genitalia]. Ann Ostet Ginecol Med Perinat (1992) 0.75
Effect of Chondroitin Sulphate on Pro-Inflammatory Mediators and Disease Activity in Patients with Inflammatory Bowel Disease. Digestion (2015) 0.75
Immune pathogenesis of hepatitis B. Arch Virol Suppl (1992) 0.75
[Uses, role and limitations of computerized tomography (CT) in mediastinal and cardiac diagnostics and the prospects of use of new related methods]. Clin Ter (1984) 0.75
Clinical features of hepatitis delta virus infection in a northern Italian area. Infection (1988) 0.75
[A case of myocardial infarct caused by coronaritis]. Minerva Med (1982) 0.75
[Diuretics in cardiovascular pathology. Their clinical use in the light of recent pathogenetic studies]. Minerva Med (1984) 0.75
[Electrocardiographic findings in a group of treated with mitral commissurotomy]. Boll Soc Ital Cardiol (1966) 0.75
[Correlations between trophism of the external genitalia and hormone levels during menopausal age]. Ann Ostet Ginecol Med Perinat (1991) 0.75
[Radiological findings in a group of subjects treated with mitral commissurotomy]. Boll Soc Ital Cardiol (1966) 0.75